• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    MOLECULAR DETERMINANTS OF HUMAN ANTIBODY MEDIATED INHIBITION OF HUMAN NOROVIRUS

    Alvarado, Gabriela S.
    : https://etd.library.vanderbilt.edu/etd-03112019-205444
    http://hdl.handle.net/1803/15370
    : 2019-03-12

    Abstract

    Human noroviruses (HuNoVs) are the leading cause of acute nonbacterial gastroenteritis and are responsible for 19-21 million cases of infection in the U.S. each year. There are currently no licensed vaccines, therapeutics, or prophylactics available to prevent or treat NoV infection. NoVs are classified into at least 6 phylogenetically distinct genogroups and are further subdivided into more than 31 genotypes. Viruses of genogroup I (GI) and a rapidly evolving genogroup II (GII) account for nearly all human infections. The antigenic variation among HuNoV strains has made developing an effective broadly cross-protective vaccine extremely challenging. Identifying the determinants of human antibody-antigen recognition and mapping blockade epitopes will define the HuNoV antigenic sites that could be used to design broadly protective vaccine candidates. I hypothesized that NoV infection induces genotype-specific and inter- or intra-genogroup I and II cross-reactive broadly blocking, or neutralizing, human antibodies, and that neutralization is mediated by Abs binding near the receptor binding domain. Several genotype-specific or cross-reactive broadly binding and broadly neutralizing human mAbs were identified and three-dimensional structural studies determined neutralizing epitopes on both a GI and GII variants. All isolated human mAbs also have the potential to be used for diagnostic or therapeutic purposes. Identifying anti-NoV human mAbs and defining blockade epitopes can provide valuable necessary insight for rational vaccine design efforts.
    Show full item record

    Files in this item

    Icon
    Name:
    GAlvaradoDissertationPDF.pdf
    Size:
    23.99Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy